Cardiology -
Grand Rounds
Topic: Cardiac Amyloidosis: Under-diagnosed and Treatable
When:
Friday, March 15, 2024
12:00 PM - 1:00 PM
ZOOM Meeting
Speaker:
Mathew Maurer, M.D.
Columbia University Irving Medical Center
Target Audience:
Community Physicians, Faculty, Residents/Fellows, Staff/Employees
Learning Objectives
Upon completion of the presentation, participants will be able to:
Upon completion of this activity, participants should be able to:
• To facilitate early diagnosis of cardiac amyloidosis
• To understand pitfalls to a non-biopsy diagnostic approach to transthyretin cardiac amyloidosis
• To enumerate three strategies for treating transthyretin cardiac amyloidosis
Accreditation
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit
The University of Florida College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the Activity.
Disclosure
Dr. Mathew Maurer has disclosed that he is a consultant for Alnylam, Intellia, Astra Zeneca, Novo-Nordisk, BridgeBi0 and provides research support to Pfizer, Alnylam, Ionis, Attralus, Intellia, and Eidos.
Dr. Angiolillo has disclosed that he has received payment as an individual for Consulting fees or honorarium from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, Boehringer lngelheim, Bristol-Myers Squibb, Chiesi, DaiichiSankyo, Eli Lilly, Haemonetics, Janssen, Merck, PhaseBio, Plx Pharma, Pfizer, and Sanofi. Institutional payments for grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, DaiichiSankyo, Eisai, Eli-Lilly, Gilead, ldorsia, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, Osprey Medical, Renal Guard Solutions and the Scott R. MacKenzie Foundation.
No one else is in a position to control content has any financial relationships to disclose. No one else in a position to control content has any financial relationships to disclose.
For additional information, contact Stacey Wice (904) 244-3932 stacey.wice@jax.ufl.edu.